Home

Évszak kiásás Egy jó barát erradication of disease selection marker vaccine Meggyőző Nyíl ciklus

MMWR COVID-19 Reports | MMWR
MMWR COVID-19 Reports | MMWR

Intranasal vaccination with a Newcastle disease virus-vectored vaccine  protects hamsters from SARS-CoV-2 infection and disease - ScienceDirect
Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease - ScienceDirect

Spherical nucleic acids as an infectious disease vaccine platform | PNAS
Spherical nucleic acids as an infectious disease vaccine platform | PNAS

The role of vaccines in combatting antimicrobial resistance | Nature  Reviews Microbiology
The role of vaccines in combatting antimicrobial resistance | Nature Reviews Microbiology

Vaccines | Free Full-Text | Progress and Prospects on Vaccine Development  against SARS-CoV-2
Vaccines | Free Full-Text | Progress and Prospects on Vaccine Development against SARS-CoV-2

Vaccines | Free Full-Text | Expression of SARS-CoV-2 Spike Protein Receptor  Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential  COVID-19 Oral Vaccine Candidate
Vaccines | Free Full-Text | Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate

Disease Eradication: What Does It Take to Wipe out a Disease?
Disease Eradication: What Does It Take to Wipe out a Disease?

Efficient Bacterial Genome Engineering throughout the Central Dogma Using  the Dual-Selection Marker tetAOPT | ACS Synthetic Biology
Efficient Bacterial Genome Engineering throughout the Central Dogma Using the Dual-Selection Marker tetAOPT | ACS Synthetic Biology

A Covid-19 Milestone Attained — A Correlate of Protection for Vaccines |  NEJM
A Covid-19 Milestone Attained — A Correlate of Protection for Vaccines | NEJM

B and T cell response to SARS-CoV-2 vaccination in health care  professionals with and without previous COVID-19 - eBioMedicine
B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19 - eBioMedicine

Development of a gene-deleted live attenuated candidate vaccine against  fish virus (ISKNV) with low pathogenicity and high protection -  ScienceDirect
Development of a gene-deleted live attenuated candidate vaccine against fish virus (ISKNV) with low pathogenicity and high protection - ScienceDirect

Frontiers | SARS-CoV-2 Variants, Vaccines, and Host Immunity
Frontiers | SARS-CoV-2 Variants, Vaccines, and Host Immunity

Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine  dosing regimes | Science
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes | Science

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers | NEJM
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers | NEJM

Disparities in COVID-19 Vaccination Coverage Between Urban and Rural  Counties — United States, December 14, 2020–April 10, 2021 | MMWR
Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — United States, December 14, 2020–April 10, 2021 | MMWR

Biomaterial vaccines capturing pathogen-associated molecular patterns  protect against bacterial infections and septic shock | Nature Biomedical  Engineering
Biomaterial vaccines capturing pathogen-associated molecular patterns protect against bacterial infections and septic shock | Nature Biomedical Engineering

Vaccines | Free Full-Text | A Newcastle Disease Virus (NDV) Expressing a  Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine
Vaccines | Free Full-Text | A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine

Live attenuated vaccines, a favorable strategy to provide long-term  immunity against protozoan diseases: Trends in Parasitology
Live attenuated vaccines, a favorable strategy to provide long-term immunity against protozoan diseases: Trends in Parasitology

Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection  during the delta (B.1.617.2) variant surge in India: a test-negative, case- control study and a mechanistic study of post-vaccination immune responses  - The Lancet Infectious
Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case- control study and a mechanistic study of post-vaccination immune responses - The Lancet Infectious

Vaccination and immunotherapies in neuroimmunological diseases | Nature  Reviews Neurology
Vaccination and immunotherapies in neuroimmunological diseases | Nature Reviews Neurology

A mass spectrometry guided approach for the identification of novel vaccine  candidates in gram-negative pathogens | Scientific Reports
A mass spectrometry guided approach for the identification of novel vaccine candidates in gram-negative pathogens | Scientific Reports

Animals | Free Full-Text | Transboundary Animal Diseases, an Overview of 17  Diseases with Potential for Global Spread and Serious Consequences
Animals | Free Full-Text | Transboundary Animal Diseases, an Overview of 17 Diseases with Potential for Global Spread and Serious Consequences

Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis: Trends in  Molecular Medicine
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis: Trends in Molecular Medicine

Frontiers | Novel Vaccine Technologies in Veterinary Medicine: A Herald to  Human Medicine Vaccines
Frontiers | Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines

Vaccines have helped eradicate major diseases in the US | World Economic  Forum
Vaccines have helped eradicate major diseases in the US | World Economic Forum